当前位置:首页 - 行情中心 - 康众医疗(688607) - 财务分析 - 现金流量表

康众医疗

(688607)

  

流通市值:54.74亿  总市值:60.81亿
流通股本:7932.90万   总股本:8812.90万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金72,631,373.74331,316,422.38235,619,980.16148,230,647.82
  收到的税费返还4,724,611.9710,388,733.9110,824,485.165,545,942.83
  收到其他与经营活动有关的现金4,727,814.2912,113,837.196,549,275.866,576,173.45
  经营活动现金流入小计82,083,800353,818,993.48252,993,741.18160,352,764.1
  购买商品、接受劳务支付的现金53,683,098.16288,957,710.75218,098,992.12131,496,317.19
  支付给职工以及为职工支付的现金25,410,544.5387,277,189.2963,833,440.7344,757,651.83
  支付的各项税费3,719,366.517,744,393.410,323,493.25,218,509.53
  支付其他与经营活动有关的现金16,097,258.1642,458,172.0834,339,024.328,235,390.7
  经营活动现金流出小计98,910,267.36426,437,465.52326,594,950.35209,707,869.25
  经营活动产生的现金流量净额-16,826,467.36-72,618,472.04-73,601,209.17-49,355,105.15
二、投资活动产生的现金流量:
  取得投资收益收到的现金54,528.664,545,211.74,393,788.882,851,736.11
  处置固定资产、无形资产和其他长期资产收回的现金净额936,000151,507.18133,122.56133,657.17
  收到的其他与投资活动有关的现金20,000,1001,772,124,5001,314,124,5001,048,510,000
  投资活动现金流入小计20,990,628.661,776,821,218.881,318,651,411.441,051,495,393.28
  购建固定资产、无形资产和其他长期资产支付的现金3,962,240.0565,825,012.8328,442,129.3625,706,424.91
  投资支付的现金6,000,00038,000,00030,000,00020,000,000
  支付其他与投资活动有关的现金20,000,0001,627,768,2001,299,768,100991,419,600
  投资活动现金流出小计29,962,240.051,731,593,212.831,358,210,229.361,037,126,024.91
  投资活动产生的现金流量净额-8,971,611.3945,228,006.05-39,558,817.9214,369,368.37
三、筹资活动产生的现金流量:
  吸收投资收到的现金-307,235.94310,456.25309,725.99
  取得借款收到的现金10,000,00067,335,708.3350,000,00020,000,000
  筹资活动现金流入小计10,000,00067,642,944.2750,310,456.2520,309,725.99
  偿还债务支付的现金79,430.437,585,236.8617,585,236.862,585,236.86
  分配股利、利润或偿付利息支付的现金-5,954,225.825,330,870.245,370,197.09
  支付其他与筹资活动有关的现金-4,599,288.693,536,067.29966,786.8
  筹资活动现金流出小计79,430.448,138,751.3726,452,174.398,922,220.75
  筹资活动产生的现金流量净额9,920,569.619,504,192.923,858,281.8611,387,505.24
四、汇率变动对现金及现金等价物的影响-2,348,540.5-2,004,275.19-721,823.52893,930.63
五、现金及现金等价物净增加额-18,226,049.65-9,890,548.28-90,023,568.75-22,704,300.91
  加:期初现金及现金等价物余额213,409,588.09221,907,862.48221,907,862.48221,907,862.48
  期末现金及现金等价物余额195,183,538.44212,017,314.2131,884,293.73199,203,561.57
补充资料:
  净利润--7,328,974.37--678,824.81
  资产减值准备-7,511,901.06--85,757.17
  固定资产和投资性房地产折旧-2,839,230.09-1,406,680.69
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-2,839,230.09-1,406,680.69
  无形资产摊销-331,806.76-167,221.6
  长期待摊费用摊销-4,623,619.13-1,594,478.96
  处置固定资产、无形资产和其他长期资产的损失--147,888.49--5,515.14
  固定资产报废损失-121,525.46-121,271.72
  公允价值变动损失--2,251,205.92-313,217
  财务费用-1,098,504.58-215,346.93
  投资损失--941,705.16--821,072.79
  递延所得税--2,929,491.2--2,194,235.79
  其中:递延所得税资产减少--2,636,406.64--1,916,512.58
    递延所得税负债增加--293,084.56--277,723.21
  存货的减少--76,626,971.08--41,712,051.17
  经营性应收项目的减少--32,043,038.82--19,424,654.12
  经营性应付项目的增加-12,125,843.08-433,551.83
  其他--556,320-420,035.85
  现金的期末余额-212,017,314.2-199,203,561.57
  减:现金的期初余额-221,907,862.48-221,907,862.48
  现金及现金等价物的净增加额--9,890,548.28--22,704,300.91
公告日期2026-04-252026-04-252025-10-232025-08-23
审计意见(境内)标准无保留意见
TOP↑